These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 25778686

  • 21. Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
    Jin J, Wang J, Lu Y, Fan Z, Huang N, Ma L, Yu H.
    Indian J Pediatr; 2019 Mar; 86(3):250-255. PubMed ID: 30159809
    [Abstract] [Full Text] [Related]

  • 22. [Relationship between heart rate variability and coronary artery lesion in children with Kawasaki disease].
    Chen TT, Shi K, Liu YL, Guo YH, Li Y, Wang XM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):607-12. PubMed ID: 26108324
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
    Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
    [Abstract] [Full Text] [Related]

  • 24. Expression levels of plasma miRNA-21 and NT-proBNP in children with Kawasaki disease and their clinical significance.
    Zhang R, Wu L, Zhang HJ, Gao XJ, Pan XT, Wang XR, Ye H, Liu GH.
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12757-12762. PubMed ID: 33378024
    [Abstract] [Full Text] [Related]

  • 25. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
    Peng Q, Wu Q, Chen CH, Hong H, Zhang LY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
    [Abstract] [Full Text] [Related]

  • 26. Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.
    Lu Y, Chen T, Wen Y, Si F, Wu X, Yang Y.
    BMC Pediatr; 2021 Sep 16; 21(1):406. PubMed ID: 34530763
    [Abstract] [Full Text] [Related]

  • 27. Meta-analysis: Diagnostic Value of N-Terminal Pro-brain Natriuretic Peptide for Kawasaki Disease.
    Yu J, Li HH, Dong L.
    Clin Lab; 2016 Oct 01; 62(10):1903-1910. PubMed ID: 28164518
    [Abstract] [Full Text] [Related]

  • 28. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 01; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 29. Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.
    Kaneko K, Yoshimura K, Ohashi A, Kimata T, Shimo T, Tsuji S.
    Pediatr Cardiol; 2011 Dec 01; 32(8):1106-9. PubMed ID: 21487793
    [Abstract] [Full Text] [Related]

  • 30. Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis.
    Lin KH, Chang SS, Yu CW, Lin SC, Liu SC, Chao HY, Lee MT, Wu JY, Lee CC.
    BMJ Open; 2015 Apr 14; 5(4):e006703. PubMed ID: 25872939
    [Abstract] [Full Text] [Related]

  • 31. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.
    Satoh K, Wakejima Y, Gau M, Kiguchi T, Matsuda N, Takasawa R, Takasawa K, Nishioka M, Shimohira M.
    Int J Rheum Dis; 2018 Mar 14; 21(3):746-754. PubMed ID: 29105337
    [Abstract] [Full Text] [Related]

  • 32. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
    Zhonghua Er Ke Za Zhi; 2006 Dec 14; 44(12):891-5. PubMed ID: 17254453
    [Abstract] [Full Text] [Related]

  • 33. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
    Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
    Ann Med; 2023 Dec 14; 55(2):2264315. PubMed ID: 37870383
    [Abstract] [Full Text] [Related]

  • 34. [Serum levels of interleukin-38 and interleukin-1β in the acute phase of Kawasaki disease in children].
    Zhang XY, He T, Ling JY, Hu XF, Wen Y, Wei J, Lu HL.
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul 14; 20(7):543-548. PubMed ID: 30022755
    [Abstract] [Full Text] [Related]

  • 35. Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP).
    Desjardins L, Dionne A, Meloche-Dumas L, Fournier A, Dahdah N.
    Pediatr Cardiol; 2020 Jun 14; 41(5):947-954. PubMed ID: 32172336
    [Abstract] [Full Text] [Related]

  • 36. Blood N-terminal Pro-brain Natriuretic Peptide and Interleukin-17 for Distinguishing Incomplete Kawasaki Disease from Infectious Diseases.
    Wu L, Chen Y, Zhong S, Li Y, Dai X, Di Y.
    Indian Pediatr; 2015 Jun 14; 52(6):477-80. PubMed ID: 26121721
    [Abstract] [Full Text] [Related]

  • 37. Value of the N-terminal of prohormone brain natriuretic peptide in diagnosis of Kawasaki disease.
    Ye Q, Shao WX, Shang SQ, Zhou MM.
    Int J Cardiol; 2015 Jan 15; 178():5-7. PubMed ID: 25464207
    [No Abstract] [Full Text] [Related]

  • 38. Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.
    Connelly MA, Shimizu C, Winegar DA, Shalaurova I, Pourfarzib R, Otvos JD, Kanegaye JT, Tremoulet AH, Burns JC.
    BMC Pediatr; 2016 Sep 05; 16(1):151. PubMed ID: 27596163
    [Abstract] [Full Text] [Related]

  • 39. A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease.
    Joung J, Oh JS, Yoon JM, Ko KO, Yoo GH, Cheon EJ.
    BMC Pediatr; 2022 Aug 05; 22(1):474. PubMed ID: 35931986
    [Abstract] [Full Text] [Related]

  • 40. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
    Nandi A, Pal P, Basu S.
    Rheumatol Int; 2019 Oct 05; 39(10):1797-1801. PubMed ID: 31302740
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.